Cocaine Use Reduction with Buprenorphine (CURB)
Walter Ling, M.D. Lead Investigator Director, Integrated Substance Abuse Programs, UCLA 11075 Santa Monica Boulevard Suite 225 Los Angeles, CA 90025 lwalter@ix.netcom.com

This study aims to determine whether buprenorphine can reduce cocaine use independent of its effect in reducing opioid use. The primary outcome will be cocaine use as reflected by Treatment Effectiveness Score (TES) throughout the study, with emphasis on the urine test results from the final 3 weeks of treatment. Secondary outcomes will be retention and level of other drug use, particularly opioids/opiates, as well as methamphetamine, alcohol, methadone, and benzodiazepines.

	Find publications in the Library about Protocol CTN-0048